Resources

20
Aug

POSTER – High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin

Vaccine DevelopmentGenerate human immunological insights with a comprehensive solution for vaccine development Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural
Read more
8
Aug

Accelerating vaccine development with transcriptomics

Accelerating Vaccine Development with TranscriptomicsThe landscape of vaccine development is undergoing a significant transformation with the advent of transcriptomic approaches. These technologies offer unprecedented insights into the complexities of the immune system, enabling the creation of more effective and targeted vaccines. Understanding Transcriptomics In the cutting-edge field of vaccine development, transcriptomics stands out as a revolutionary approach, offering unprecedented insights
Read more
22
Jul

Injection-Site Pain

Injection-Site PainWhich factors influence pain upon subcutaneous injection?Biologics such as vaccines, insulin, monoclonal antibodies, etc., that are now widely developed need to be administered parenterally. While the intravenous (IV) route has historically been the most widely used,  the subcutaneous (SC) route is now accepted and presented as safe and effective, whether in the context of chronic disease or in palliative
Read more
12
Jul

Immunogenicity series: Evaluating and managing immunogenicity for vaccines

Immunogenicity SeriesPart 4 - Evaluating and managing immunogenicity for vaccinesImmunogenicity is crucial in vaccine development, it represents the capacity of a substance, such as a vaccine, to elicit an immune response. This reaction can be beneficial, providing protection against diseases, or detrimental, resulting in adverse effects. In vaccine development, the goal is to trigger on-target immunogenicity to activate the immune
Read more
8
Jul

A unique human skin model to study subcutaneous injections

HypoSkin®, an ex vivo human skin model to predict toxicity & efficacy of subcutaneous drugs Recent advancements in subcutaneous injection testing have brought about significant improvements in drug delivery and patient experience. These advancements include the development of innovative injection devices and formulations that enhance the ease and comfort of subcutaneous drug administration. Market trends also indicate a growing demand
Read more
2
Jul

PROTOCOL – Subcutaneous injection

ProtocolSubcutaneous InjectionPlease fill in the form below to access the protocol. Need more info? Please contact us! Contact us